arXiv Science⌕ Search

arXiv · 2610.05477

PKComb-BOIN12: A Pharmacokinetically Guided Bayesian Design for Dose Optimisation in Oncology Drug-Combination Trials

Abstract

Dose optimisation of two-agent combinations in early-phase oncology trials must jointly balance toxicity, efficacy, and pharmacologically meaningful drug exposure, yet existing model-assisted combination designs use only binary toxicity--efficacy outcomes and leave pharmacokinetic (PK) data unused for dosing decisions. We propose PKComb-BOIN12, a utility-based Bayesian optimal interval design embedding a continuous PK exposure metric into two-agent dose optimisation via a PK-guided escalation rule and a PK-sufficiency constraint on the final admissible set. Two contributions distinguish this design from a direct combination extension of existing single-agent PK-informed designs. First, PK-based elimination uses a coordinatewise order-ideal (down-set) removal rule, so that eliminating a combination for insufficient exposure is licensed exactly by the assumed monotonicity of exposure in each agent's dose, rather than an unjustified scalar summary of combined dose intensity. Second, the pre-specified target exposure is treated as transportable-but-verifiable: a hierarchical calibration mechanism updates the assumed monotherapy-derived target using accruing combination-arm PK data, with a formal bound on the resulting selection bias under transportability violations. A time-to-event extension, TITE-PKComb-BOIN12, accommodates late-onset outcomes. A factorial simulation study spanning realistic scenarios, including one calibrated to a published combination trial, decomposes the source of PKComb-BOIN12's gains over its non-PK predecessor and evaluates robustness to non-monotone exposure, PK-variance misspecification, and target-transportability violations. An R Shiny application supports design evaluation and real-time conduct.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Jieqi Tu, Ruitao Lin, Ayon Mukherjee. 2026-10-04. PKComb-BOIN12: A Pharmacokinetically Guided Bayesian Design for Dose Optimisation in Oncology Drug-Combination Trials. https://arxiv.org/abs/2610.05477

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related papers

GARCH copulas, v-transforms and D-vines for stochastic volatility

The bivariate copulas that describe the dependencies and partial dependencies of lagged variables in strictly stationary, first-order GARCH-type processes are investigated. It is shown that the copulas of symmetric GARCH processes are jointly symmetric but non-exchangeable, while the copulas of processes with symmetric innovation distributions and asymmetric leverage effects have weaker h-symmetry; copulas with asymmetric innovation distributions have neither form of symmetry. Since the true bivariate copulas are typically inaccessible, due to the unknown functional forms of the marginal distributions of GARCH processes, a new class of approximating copulas is proposed. These rely on copula density constructions that combine standard bivariate copula densities for positive dependence with two uniformity-preserving transformations known as v-transforms. The construction is shown to be particularly effective when applied to the density of the copula of the absolute values of a spherical t distribution. Tractable simplified D-vines incorporating the new pair copulas are developed for applications to time series showing stochastic volatility. The resulting models are shown to provide better fits to simulated data from GARCH processes, and to a dataset of financial exchange-rate returns, than have previously been obtained using vine copulas.

stat.ME↗

Selecting Informative Conformal Prediction Sets with an Optimized FCR-Controlled Approach

Conformal methods provide prediction sets for outcomes with confidence guarantees. We study their use in a selective inference setting, where inference is performed only when the prediction set is informative. The analyst may consider as informative, for example, cases with prediction sets that are sufficiently small, exclude null values, or satisfy other appropriate monotone constraints. Because inference is typically restricted to informative cases in practical applications, accounting for the resulting selection bias is crucial to maintaining false coverage rate (FCR) control. A general framework for constructing such informative conformal prediction sets while controlling the FCR on the selected sample was suggested in Gazin et al. (2025). In this work we focus on oracle-guided procedures. We derive the optimal decision policy under a suitable power objective in the oracle setting where the probability of belonging to each prediction set can be computed. In practice, of course, only estimated probabilities are available. We therefore introduce calibration procedures that adjust the oracle policy to maintain finite-sample FCR control. We show that this approach can achieve substantially higher power than available alternatives. We demonstrate the effectiveness of our new methods for classification outcomes on both real and simulated data.

stat.ME↗

Model--based clustering for spherical and hyper--spherical data using elliptically symmetric distributions

Model--based clustering for directional data data has attracted a lot of interest, but most methods utilize rotationally symmetric distributions. This paper suggests the use of elliptically symmetric distributions, namely the elliptically symmetric angular Gaussian and the spherical elliptically symmetric projected Cauchy distributions that were recently proposed in the literature for modelling spherical data. The expectation--maximization algorithm is employed and the inclusion of covariates is also examined. Simulation studies compare the two distributions in terms of choosing the optimal number of clusters and computational cost. We use the mixtures of these two distributions to cluster two datasets on the sphere (earthquake locations) and two hyper--spherical datasets.

stat.ME↗